Advertisement
Advertisement
IMMP
Immutep Limited - ADR
2.63
USDSponsored
0.00
+0.19%
Feb 06, 15:59 UTC -5
Closed
After-Market
2.62
0.00
-0.19%
IMMP Earnings Reports
Positive Surprise Ratio
IMMP beat 6 of 9 last estimates.
67%
Next Report
Date of Next Report
Feb 24, 2026
Estimate for Q2 26 (Revenue/ EPS)
$17.22M
/-$0.02
Implied change from Q-- -- (Revenue/ EPS)
--
/--
Implied change from Q2 25 (Revenue/ EPS)
+136.68%
/+100.00%
Immutep Limited - ADR earnings per share and revenue
On --, IMMP reported earnings of -- USD per share (EPS) for -- --, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to Q2 26, 2 analysts forecast an EPS of -0.02 USD, with revenue projected to reach 17.22 million USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Amgen Inc
Report Date
Feb 03, 2026 For Q4 25
Estimate
$4.82
Actual
$5.29
Surprise
+9.56%
Bristol-Myers Squibb Co.
Report Date
Feb 05, 2026 For Q4 25
Estimate
$1.12
Actual
$1.26
Surprise
+11.88%
GSK plc - ADR
Report Date
Feb 04, 2026 For Q4 25
Estimate
$0.23
Actual
$0.49
Surprise
+111.36%
Biogen Inc. Common Stock
Report Date
Feb 06, 2026 For Q4 25
Estimate
$1.62
Actual
$1.99
Surprise
+22.39%
Illumina Inc
Report Date
Feb 05, 2026 For Q4 25
Estimate
$1.24
Actual
$1.35
Surprise
+8.01%
QIAGEN N.V.
Report Date
Feb 04, 2026 For Q4 25
Estimate
$0.64
Actual
$0.62
Surprise
-3.32%
Arrowhead Research Corporation
Report Date
Feb 05, 2026 For Q1 26
Estimate
$0.25
Actual
$0.22
Surprise
-14.76%
Bio-Techne Corp.
Report Date
Feb 04, 2026 For Q2 26
Estimate
$0.44
Actual
$0.46
Surprise
+3.95%
Immunovant, Inc. Common Stock
Report Date
Feb 06, 2026 For Q3 26
Estimate
-$0.72
Actual
-$0.61
Surprise
+16.27%
Adaptive Biotechnologies Corporation Common Stock
Report Date
Feb 05, 2026 For Q4 25
Estimate
-$0.18
Actual
-$0.09
Surprise
+51.33%
FAQ
What were Immutep Limited - ADR's earnings and revenue for the latest quarter Q-- --?
For Q-- --, Immutep Limited - ADR reported EPS of --, Inline estimates by --, and revenue of --, -- -- expectations.
How did the market react to Immutep Limited - ADR's Q-- -- earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is Immutep Limited - ADR expected to report next?
The next earning report is scheduled for Feb 24, 2026.
What are the forecasts for Immutep Limited - ADR's next earnings report?
Based on 2
analysts, Immutep Limited - ADR is expected to report EPS of -$0.02 and revenue of $17.22M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement